首页
外语
计算机
考研
公务员
职业资格
财经
工程
司法
医学
专升本
自考
实用职业技能
登录
外语
Doctors at Stanford University are studying a medication they hope will alleviate the suffering of millions of American women. B
Doctors at Stanford University are studying a medication they hope will alleviate the suffering of millions of American women. B
admin
2013-01-25
73
问题
Doctors at Stanford University are studying a medication they hope will alleviate the suffering of millions of American women. But their target isn’t breast cancer, osteoporosis, or a similarly well-known affliction. Despite its alarming impact on its victims, the malady in question has received comparatively little medical scrutiny. It’s a "hidden epidemic," according to the Stanford researchers: compulsive shopping disorder.
That’s right. What was once merely a punchline in television sitcoms is now being taken seriously by many clinicians. According to the Stanford study’s leader, Dr. Lorrin Koran, compulsive shopping is "motivated by ’irresistible’ impulses, characterized by spending that is excessive and inappropriate, has harmful consequences for the individual, and tends to be chronic and stereotyped." Compulsive shoppers "binge buy" --most often clothes, shoes, makeup, and jewelry--and then suffer intense guilt. That, in turn, helps trigger another frenzied trip to the mall, and the cycle continues.
Could compulsive shopping be a health hazard associated with America’s unparalleled economic prosperity? "It seems to be a disease of affluence," says Dr. Jerrold Pollak, a clinical psychologist who’s treated several shopaholics. "Advertisers... would like us to think that shopping is a reason to live," agrees Dr. Cheryl Carmin, another clinical psychologist. "If you do not have the time or inclination to go to the mall or grocery store, there are catalogs, delivery services, home shopping networks on TV, and endless items to buy via the Internet." Indeed, this year, US advertisers will spend $ 233 billion--an amount equal to six federal education budgets to persuade Americans to buy, buy, buy.
Yet the possibility that US advertisers may be driving certain women in our society t9 psychosis is only part of the story. It seems that the pharmaceutical companies’ quest to cure the effects of excessive marketing may itself be little more than a cleverly-disguised marketing scheme. The Stanford study, like many of its kind, is being funded by a pharmaceutical company. The undisclosed drug is an FDA-approved antidepressant, specifically an SSRI--a selective serotonin re-uptake inhibitor. (The researchers are also studying behavioral therapies for compulsive shoppers.)
The researchers running the Stanford study refused to reveal their sponsor. However, only five SSRIs are currently on the US market. Pfizer (makers of Zolofi), Eli Billy (Prozac) and SmithKline Beecham (Paxil) all reported that they are neither conducting nor planning any studies of their drugs for compulsive shopping. Solvay (Luvox)also seems an unlikely candidate. In 1997, researchers at the University of Iowa tried using Luvox to treat compulsive shoppers and found no measurable differences between the effects of the drug and those of a placebo. Perhaps the manufacturers of Luvox want to give their product another shot. More likely, however, the mysterious benefactor of the Stanford Study is Forest Pharmaceuticals (Celexa). Their PR department neither confirmed nor denied any involvement in Koran’s study.
Why would a pharmaceutical company anonymously spend money to license one of its top-selling drugs for a marginal disorder like compulsive shopping? A big part of the answer is profit. The mystery company presumably hopes to carve a unique slice out of the mental disorder pie in order to market it together with a ready-made treatment. This is not at all a new strategy for the world’s mammoth pharmaceutical firms, as David Healy, a professor at the University of Wales College of Medicine, explains in his book "The Anti- Depressant Em." Healy’s book describes a process by which companies Seek to "educate" both patients and clinicians about a new disorder, to sell the disorder in preparation for selling its cure. Funding clinical trials is a crucial part of that process.
The manufacturer of which of the following SSRIs is most possibly the sponsor of the Stanford study?
选项
A、Zolofi.
B、Prozac.
C、Luvox.
D、Celexa.
答案
D
解析
该题要求理解第五段的内容。不难看出,D项为正确答案。
转载请注明原文地址:https://kaotiyun.com/show/hm1O777K
0
考博英语
相关试题推荐
Beforethemid-nineteenthcentury,peopleintheUnitedStateeatmostfoodsonlyinseason.Drying,smoking,andsaltingcould
Themanagerjust____hisresignationtotheboardmeetingyesterdayandtodayanotheronetookhisplace.
ForumfortheFuture,workingwithTescoandUnilever,reckonthatby2022whatwebuy,howwebuyitandwhofromwillhavechange
Ourresearchhasfocusedonadrugwhichisso________astobeabletochangebrainchemistry.
Smugglingisa________activitywhichmightbringdestructiontooureconomy;therefore,itmustbebanned.
BackinSeattle,aroundthecornerfromtheDiscoveryInstitute,StephenMeyerofferssomepeer-reviewedevidencethattheretruly
Thenaturalenvironmentstillmanagestofilluswithasenseofaweandamazement.Despitetheamountofscientificknowledgem
Theschemewas____whenitwasdiscovereditwouldbeverycostly.
Althoughanydestructionofvitaminscausedbyfoodirradiationcouldbe______theuseofdietsupplements,theremaybenoprot
Hurricanesareviolentstormsthatcausemillionsofdollarsinpropertydamageandtakemanylives.Theycanbeextremelydange
随机试题
关于CIF,根据{2010年国际贸易术语解释通则》,下列说法错误的是()
合资经营
下列不属于莎士比亚四大悲剧的是()
A.左旋多巴B.金刚烷胺C.溴隐亭D.硫必利E.安坦氯丙嗪引起的迟发性运动障碍的解救药
解热镇痛抗炎药的主要副作用 A.肝损伤 B.肾损伤 C.胃肠道损害 D.粒细胞减少 E.心脑血管意外罗非昔布可引起
下列关于法的效力的表述中,正确的有()。
排水固结法处理地基,当采用ψ7cm袋装砂井和塑料排水板作为竖向通道时,竖向排水通道长度主要取决于工程要求和土层情况,对以地基稳定性控制的工程,竖向排水通道深度至少应超过最危险滑动面()m。
某房地产开发公司开发一住宅项目,取得该土地使用权所支付的金额3000万元,房地产开发成本4000万元,利息支出500万元(能提供金融机构贷款证明),所在省人民政府规定,能提供金融机构贷款证明的,其房地产开发费用扣除比例为4%,该公司计算土地增值税时允许扣除
为了使DHCP服务器能为Windows平台的主机服务,必须要在LINUX服务器上加上一条255.255.255.255的路由(因为Windows平台的主机都是以广播方式搜索DHCP服务器)为了以后每次启动时自动执行,应该在/etc/rtc.d/rc.loc
A、Theyaregoodatfightingantibiotics.B、Theyareresistanttoanyantibiotics.C、Theycannotsurviveacoupledrugs.D、Theya
最新回复
(
0
)